 |
| Welcome to the Home page of the ESTP ! |
|
| |
Cutting Edge Pathology Congress 2021
The 18th European Congress of Toxicologic Pathology will take place as a joint congress of ESTP, ESVP and ECVP (Cutting Edge Pathology Congress).
This congress will take place from 15th – 18th September 2021, in Torino (Italy).
It will comprise joint keynote lectures, parallel sessions of ESTP and ESVP/ECVP with free communications and case examples, and poster sessions. The ESTP topic will be "Biomarkers and Organ Toxicity", focused on the development and use of biomarkers in the process of preclinical development of new medicines, associated organ toxicity and the translatability of biomarkers to man. As usual, an IATP Satellite Symposium will precede the main congress.
The Societies and the Local and Scientific Organizing Committees will continue to closely monitor the situation related to the Sars-CoV-2 pandemic and will decide responsibly, latest in spring 2021, whether the format of the congress needs to be adapted to a partially or entirely virtual congress.
|
|
Further ESTP news and announcements:
 |
|
|
 ESTP newsletter 2020 (2)
The second ESTP newsletter 2020 containing a President's column, search for successor in ESTP Secretary position, presentation of the new Administrative Assistant and announcements of Tox Path podcasts and joint webinars of ESTP/SFPT/BSTP and ECVP/ESVP is now available here. Previous newsletters are accessible in the repository.
[16-Oct-2020
]
|
 Guess What!
Case #27
Interesting cases from the field of toxicologic pathology are presented each year in this interactive ESTP section. The new case #27 is now available.
The solution to Case #26 has been added.
[26-Aug-2020
]
|
|
|
[30-Aug-2019
]
|
Updates to the Web site
For those visiting the Web site on a regular basis the Updates functionality is always available to find recent changes more easily.
[04-Aug-2008
]
|
|
|
The ESTP Committee for Scientific Standards (CSS) prepared a response to the recently published FDA guidance "Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers, Guidance for Industry". This draft guidance was published in the Federal register August 1st, 2019 for public comment and originated from the FDA Office of Study Integrity and Surveillance (OSIS). Herewith, we would also like to thank you those members and organizations, which have shared their comments and responses regarding this Draft guidance with us.
The finalized ESTP CSS comments have been endorsed by the ESTP Executive Committee, and were submitted electronically and by UPS to the FDA October 18th, 2019. The committee had agreed with FDA representatives an extension of the official comment period.
If you have any questions or comments, please reach out to the working group chair, Annette Romeike (annette.romeike@covance.com).
Annette Romeike, ESTP Chair of Committee for Scientific Standards, on behalf of the ESTP CSS – Sibylle Groeters, Laetita Elies, Erio Barale, Eveline de Rijk, Katrin Gutberlet, Flavia Pasello
[18-Nov-2019
]
|
|
|
|
|
17th European Congress of Toxicologic Pathology
Revision of Standardized Nomenclature